Overexpression of FBXO22 has been reported to suppress the Bach1‐driven metastasis of lung adenocarcinoma [17] and promote nuclear tumor suppressive factor PTEN downregulation to play a tumor-promoting role in colorectal cancer [47]. This evidence concerns the gene FBXO22 and colorectal cancer.